Avastin in Combination With Chemotherapy for RAS Mutant Unresectable Colorectal Liver-limited Metastases
Status:
Completed
Trial end date:
2019-06-01
Target enrollment:
Participant gender:
Summary
In this study, the investigators assessed the effect of avastin in combination with
chemotherapy in the treatment of RAS mutant-type, unresectable colorectal liver-limited
metastases